Home » Topics » BioWorld Science

BioWorld Science
RSS

Aspartate derivative with antiamnestic activity synthesized

June 14, 1996

More possible Alzheimer's treatment

June 14, 1996

XSB-1E as possible Alzheimer's treatment

June 14, 1996

MF-8622 undergoes preclinical evaluation

June 14, 1996

Warner-Lambert discloses complement C1r protease inhibitors

June 14, 1996

Polypeptides with neuroprotective/neurotrophic activity

June 14, 1996

Cephalon research reveals active compounds

June 14, 1996

RPR's riluzole approved in Europe

June 14, 1996

Myotrophin still pending full marketing approval

June 14, 1996

Xytronyx and Binary Therapeutics enter acquisition agreement

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...